Bacterial biofilms are a feature of many chronic diseases of the head/neck. Few of the topical antibiofilm agents that can be used to eradicate biofilms in vitro are suitable for otolaryngological application. Maxitrol may demonstrate antibiofilm activity and may therefore be useful in the management of biofilm-related disease in the head/neck.